This page is dedicated to the Food Protein-Induced Enterocolitis Syndrome (FPIES) research study, one of over 60 studies supported by the Boston Children’s Rare Disease Collaborative (CRDC). For more information about the CRDC, please visit our home page. Established in 2018, the CRDC supports pediatric rare disease research and provides families with genetic diagnoses that enable personalized treatments, including precision medicine and targeted therapies.
Clinical Researcher, Division of Immunology
Assistant Professor of Pediatrics, Harvard Medical School
Elana Crestani, MD
Assistant Professor of Pediatrics, Harvard Medical School
Attending Physician, Asthma and Allergy Program
The FPIES research study was established in 2025 and is led by Drs. Lisa Bartnikas and Elena Crestani.